New SARS-CoV-2 neutralizing antibody in clinical trial now » read more
Highly potent neutralizing antibodies in SARS-CoV-2 infected people identified (Cell 07/08/2020). » read more
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.
(Cell 01/30/2020) » read more
Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies (Vaccines 01/01/2020) » read more
Together with our colleagues, Steffi and Matthias decoded the antibody response to the Ebola vaccine rVSVS-ZEBOV.
(Nature Medicine 10/7/2019) » read more
Together with Rockefeller University we demonstrate prolonged viral suppression using two broadly neutralizing antibodies (Nature, 9/26/2018; Nature Medicine 9/26/2018). » read more